Drugs / N0728
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06546735 | Nov 2026 → Apr 2028 expected | benign prostatic hyperplasia | Eurofarma Laboratorios S.A. | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | N0728 | “fixed-dose combination (N0728)” NCT06546735 ↗ |